Suppr超能文献

术中核素定位辅助下的微创甲状旁腺切除术

Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping.

作者信息

Norman J, Chheda H

机构信息

Department of Surgery, University of South Florida, Tampa 33612, USA.

出版信息

Surgery. 1997 Dec;122(6):998-1003; discussion 1003-4. doi: 10.1016/s0039-6060(97)90201-4.

Abstract

BACKGROUND

The inability to predict the location and number of diseased parathyroid glands has precluded the wide acceptance of unilateral neck exploration for primary hyperparathyroidism. We used intraoperative nuclear mapping in patients identified by sestamibi scanning to have a single adenoma in hopes of minimizing operative intervention while maintaining the efficacy of a full exploration.

METHODS

Fifteen consecutive patients with primary hyperparathyroidism underwent technetium 99m-labeled sestamibi scanning 3.0 +/- 0.1 hours before operation. Placement of the initial 2.0 cm incision and all dissection were guided by quantitative gamma counting in four neck quadrants with an 11 mm Neoprobe. Ex vivo radioactivity was determined for parathyroid glands, fat, and lymph nodes. Potential radiation hazards were assessed.

RESULTS

Intraoperative nuclear mapping discriminated between 14 solitary adenomas and one patient with four-gland hyperplasia that was not predicted on preoperative sestamibi scanning. Removal of the adenoma resulted in a decline in radioactivity in that quadrant (p < 0.001) and the entire neck (p < 0.05), with equalization of all neck quadrants. Ex vivo counts always identified parathyroid tissue (p < 0.0001 versus fat and lymph node). Adenomas were located in 19 +/- 1.7 minutes through a 2.3 +/- 0.1 cm incision. No significant radiation hazard existed, and no special handling of the specimen was required (0.06 +/- 0.01 mR/hr).

CONCLUSIONS

Intraoperative nuclear mapping complements sestamibi scanning to help distinguish single-gland from multigland disease. This technique allows for a minimally invasive operation under local anesthesia in a true outpatient setting.

摘要

背景

由于无法预测甲状旁腺疾病的位置和数量,单侧颈部探查术在原发性甲状旁腺功能亢进症的治疗中尚未得到广泛应用。我们对经锝-99m甲氧基异丁基异腈(sestamibi)扫描确定为单个腺瘤的患者采用术中核素定位法,以期在保持全面探查效果的同时,尽量减少手术干预。

方法

15例连续性原发性甲状旁腺功能亢进症患者在手术前3.0±0.1小时接受了锝-99m标记的sestamibi扫描。最初2.0 cm切口的定位及所有解剖操作均在四个颈部象限通过11 mm的Neoprobe进行定量γ计数引导。测定甲状旁腺、脂肪和淋巴结的体外放射性。评估潜在的辐射危害。

结果

术中核素定位法区分出14个孤立性腺瘤和1例术前sestamibi扫描未预测到的四腺增生患者。切除腺瘤导致该象限放射性下降(p<0.001),整个颈部放射性下降(p<0.05),所有颈部象限放射性趋于均衡。体外计数总能识别出甲状旁腺组织(与脂肪和淋巴结相比,p<0.0001)。通过2.3±0.1 cm的切口在19±1.7分钟内找到腺瘤。不存在显著的辐射危害,无需对标本进行特殊处理(辐射剂量为0.06±0.01 mR/小时)。

结论

术中核素定位法可补充sestamibi扫描,有助于区分单腺疾病和多腺疾病。该技术可在真正的门诊环境中在局部麻醉下进行微创操作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验